Michaela D. Merkerova

Prague, PR 12820, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Large gold nanoparticle release assay for attomolar detection of miRNA related to myelodysplastic neoplasms.

Large gold nanoparticle release assay for attomolar detection of miRNA related to myelodysplastic neoplasms.

Journal: Talanta

Published: January 10, 2025

Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower-risk myelodysplastic neoplasms.

Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower-risk myelodysplastic neoplasms.

Journal: International journal of cancer

Published: May 01, 2023

circGPA: circRNA functional annotation based on probability-generating functions.

circGPA: circRNA functional annotation based on probability-generating functions.

Journal: BMC bioinformatics

Published: May 20, 2022

Transposable elements and Piwi‑interacting RNAs in hemato‑oncology with a focus on myelodysplastic syndrome (Review).

Transposable elements and Piwi‑interacting RNAs in hemato‑oncology with a focus on myelodysplastic syndrome (Review).

Journal: International journal of oncology

Published: June 21, 2021

Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome.

Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome.

Journal: Cells

Published: December 30, 2019

DNA methylation and hydroxymethylation patterns in acute myeloid leukemia patients with mutations in DNMT3A and IDH1/2 and their combinations.

DNA methylation and hydroxymethylation patterns in acute myeloid leukemia patients with mutations in DNMT3A and IDH1/2 and their combinations.

Journal: Cancer biomarkers : section A of Disease markers

Published: April 17, 2019

MicroRNA profiles as predictive markers of response to azacitidine therapy in myelodysplastic syndromes and acute myeloid leukemia.

MicroRNA profiles as predictive markers of response to azacitidine therapy in myelodysplastic syndromes and acute myeloid leukemia.

Journal: Cancer biomarkers : section A of Disease markers

Published: April 10, 2018

Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms.

Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms.

Journal: International journal of hematology

Published: March 09, 2016

TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes.

TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes.

Journal: Oncotarget

Published: January 03, 2016

Molecular patterns of diffuse and nodular parathyroid hyperplasia in long-term hemodialysis.

Molecular patterns of diffuse and nodular parathyroid hyperplasia in long-term hemodialysis.

Journal: American journal of physiology. Endocrinology and metabolism

Published: December 16, 2015

Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide.

Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide.

Journal: European journal of haematology

Published: October 01, 2014

Two SAPP2 gene homologs are present in Candida parapsilosis genome.

Two SAPP2 gene homologs are present in Candida parapsilosis genome.

Journal: Folia microbiologica

Published: July 29, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026